Westlake Omics ^Company

Westlake Omics focuses on applying mass spectrometry-based proteomics and other Omics technologies to address pressing clinical needs. It is committed to making breakthroughs in precision medicine and drug R&D with an unwavering focus on critical issues that impact life and health. This vision is driven by AI-empowered high-throughput proteomic analysis of minute amounts of clinical specimens and Omics technologies, supported by technological innovation and multi-modal big data.

It was founded in 2020 and is based in Hangzhou, Zhejiang, China.